This website is intended for patients or carers for people prescribed Colobreathe® (colistimethate sodium) living in the UK. The information on this website is intended to supplement, not replace, discussions with your healthcare team and should also be used in conjunction with the Patient Information Leaflet provided with your medicine. Information about the reporting of side effects can be found at the bottom of this page.
Patient Information Leaflet

COLOBREATHE® Patient Information Hub

HELPING YOU get the most out of your Colobreathe® treatment

Colobreathe® is an inhaled medication that is used to control persistent (longstanding) lung infections caused by the bacterium Pseudomonas aeruginosa in adult patients and children aged 6 years and older with cystic fibrosis.

About Colobreathe®

Want to learn more about Colobreathe®, how it works, how to use it and possible side effects?

Our About Colobreathe® page has you covered.

Learn more

Patient resources

Need a little support with your Colobreathe® treatment?

We’ve put together some useful resources to help you.

Check out resources

Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

Essential Pharma Ltd, 8A Crabtree Road, Egham, Surrey, TW20 8RN, United Kingdom
Colobreathe® is a registered trademark of Essential Pharma. Copyright © 2026 Essential Pharma
MAT-COL-GB-0007-1224 May 2025

crossmenuarrow-right